{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:23:26Z","timestamp":1792740206871,"version":"4.5.0"},"reference-count":42,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Venezuelan equine encephalitis virus (VEEV) is a highly infectious alphavirus endemic in parts of Central and South America. The disease is transmitted by mosquitoes, and the natural reservoir is the small rodent population, with epidemics occurring in horses and occasionally humans. Following infection, VEEV replicates in lymphoid tissues prior to invasion of the central nervous system. Treatment of VEEV-infected BALB\/c mice with polyethylene glycol-conjugated alpha interferon (PEG IFN-\u03b1) results in a greatly enhanced survival from either a subcutaneous or an aerosol infection. Virus is undetectable within PEG IFN-\u03b1-treated individuals by day 30 postinfection (p.i.). Treatment results in a number of changes to the immune response characteristics normally associated with VEEV infection. Increased macrophage activation occurs in PEG IFN-\u03b1-treated BALB\/c mice infected with VEEV. The rapid activation of splenic CD4, CD8, and B cells by day 2 p.i. normally associated with VEEV infection is absent in PEG IFN-\u03b1-treated mice. The high tumor necrosis factor alpha production by macrophages from untreated mice is greatly diminished in PEG IFN-\u03b1-treated mice. These results suggest key immunological mechanisms targeted by this lethal alphavirus that can be modulated by prolonged exposure to IFN-\u03b1.<\/jats:p>","DOI":"10.1128\/jvi.74.11.5006-5015.2000","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T09:55:53Z","timestamp":1027763753000},"page":"5006-5015","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":72,"title":["Pegylated Alpha Interferon Is an Effective Treatment for Virulent Venezuelan Equine Encephalitis Virus and Has Profound Effects on the Host Immune Response to Infection"],"prefix":"10.1128","volume":"74","author":[{"given":"Roman A.","family":"Lukaszewski","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->CBD, Porton Down, Salisbury, Wiltshire SP4 0JQ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J. G.","family":"Brooks","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->CBD, Porton Down, Salisbury, Wiltshire SP4 0JQ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4049\/jimmunol.154.1.9","article-title":"IL-12 activates IFN-g production through the preferential activation of CD30+ T cells","volume":"154","author":"Alzona M.","year":"1995","unstructured":"Alzona M. Jack H. M. Fisher R. I. Ellis T. M. IL-12 activates IFN-g production through the preferential activation of CD30+ T cells.J. Immunol.1541995916","journal-title":"J. Immunol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(94)90137-6"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(98)00063-1"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.10.7799-7803.1997"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.8381"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.8.1315"},{"key":"e_1_3_2_8_2","first-page":"99","article-title":"A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis","volume":"9","author":"Davis N. L.","year":"1994","unstructured":"Davis N. L. Grieder F. B. Smith J. F. Greenwald G. F. Valenski M. L. Sellon D. C. Charles P. C. Johnston R. E. A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis.Arch. Virol. Suppl.9199499109","journal-title":"Arch. Virol. Suppl."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4049\/jimmunol.157.4.1605","article-title":"Rhinovirus produces non-specific activation of lymphocytes through a monocyte-dependent mechanism","volume":"157","author":"Gern J. E.","year":"1996","unstructured":"Gern J. E. Vritis R. Kelly E. A. B. Dick E. C. Busse W. W. Rhinovirus produces non-specific activation of lymphocytes through a monocyte-dependent mechanism.J. Immunol.157199616051612","journal-title":"J. Immunol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(92)90153-G"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00008-5"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8617"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1995.1022"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.1996.0045"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9662"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(90)90213-7"},{"key":"e_1_3_2_17_2","first-page":"15","article-title":"Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69","volume":"4","author":"Isler P.","year":"1993","unstructured":"Isler P. Vey E. Zhang J. H. Dayer J. M. Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69.Eur. Cytokine Netw.419931523","journal-title":"Eur. Cytokine Netw."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/030098589102800509"},{"key":"e_1_3_2_19_2","unstructured":"Johnston R. E. Peters C. J. Alphaviruses Fields virology 3rd ed. Fields B. N. Knipe D. M. Howley P. M. Chanock R. M. Melnick J. L. Monath T. P. Roizman B. Strauss S. E. 1995 843 898 Lippincott-Raven Philadelphia Pa"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.6.1487"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/vim.1997.10.35"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.45.4.345"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1943.02840520004002"},{"key":"e_1_3_2_24_2","first-page":"7","article-title":"CD3-stimulated Jurkat T cells mediate IL-1 beta production in monocytic THP-1 cells: role of LFA-1 molecule and participation of CD69 T cell antigen","volume":"4","author":"Manie S.","year":"1993","unstructured":"Manie S. Kubar J. Limouse M. Ferrua B. Ticchioni M. Breittmayer J. P. Peyron J. F. Schaffar L. Rossi B. CD3-stimulated Jurkat T cells mediate IL-1 beta production in monocytic THP-1 cells: role of LFA-1 molecule and participation of CD69 T cell antigen.Eur. Cytokine Netw.41993713","journal-title":"Eur. Cytokine Netw."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.4049\/jimmunol.152.3.1253","article-title":"Effects of IL-12 on the response and susceptibility of experimental viral infections","volume":"152","author":"Orange J. S.","year":"1994","unstructured":"Orange J. S. Wolf S. F. Biron C. A. Effects of IL-12 on the response and susceptibility of experimental viral infections.J. Immunol.152199412531264","journal-title":"J. Immunol."},{"key":"e_1_3_2_26_2","unstructured":"Pan American Health Organization Venezuelan encephalitis Proceedings of the Workshop. Symposium on Venezuelan encephalitis virus. 1972 7 16 Pan American Health Organization Washington D.C."},{"key":"e_1_3_2_27_2","unstructured":"Peters C. J. Dalrymple J. M. Alphaviruses Virology. Fields B. N. Knipe D. M. 1990 713 761 Raven Press New York N.Y"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268896007157"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00315-6"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00168-Z"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.4.1005"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(82)90346-4"},{"key":"e_1_3_2_33_2","first-page":"607","article-title":"Venezuelan equine encephalitis virus propagation in the olfactory tract of normal and immunized mice","volume":"2","author":"Ryzhikov A. B.","year":"1991","unstructured":"Ryzhikov A. B. Tkacheva N. V. Sergeev A. N. Ryabchikova E. I. Venezuelan equine encephalitis virus propagation in the olfactory tract of normal and immunized mice.Biomed. Sci.21991607614","journal-title":"Biomed. Sci."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(91)90112-O"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.12.10286-10291.1998"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.12.2335"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.2.483"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.4049\/jimmunol.143.4.1123","article-title":"T cell activation via Leu-23 (CD69)","volume":"143","author":"Testi R.","year":"1989","unstructured":"Testi R. Phillips J. H. Lanier L. L. T cell activation via Leu-23 (CD69).J. Immunol.143198911231128","journal-title":"J. Immunol."},{"key":"e_1_3_2_39_2","first-page":"1006","article-title":"Molecular design of hybrid tumour necrosis factor-alpha III: polyethylene glycol-modified tumour necrosis factor-alpha has markedly enhanced antitumour potency due to longer plasma half-life and higher tumour accumulation","volume":"278","author":"Tsutsumi Y.","year":"1996","unstructured":"Tsutsumi Y. Kihira T. Tsunoda S. Kamada H. Nakagawa S. Kaneda Y. Kanamori T. Mayumi T. Molecular design of hybrid tumour necrosis factor-alpha III: polyethylene glycol-modified tumour necrosis factor-alpha has markedly enhanced antitumour potency due to longer plasma half-life and higher tumour accumulation.J. Pharmacol. Exp. Ther.278199610061011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1996.d01-25.x"},{"key":"e_1_3_2_41_2","first-page":"164","article-title":"Venezuelan equine encephalitis in BALB\/c mice: kinetic analysis of central nervous system infection following aerosol or subcutaneous inoculation","volume":"120","author":"Vogel P.","year":"1996","unstructured":"Vogel P. Abplanalp D. Kell W. Ibrahim M. S. Downs M. B. Pratt W. D. Davis K. J. Venezuelan equine encephalitis in BALB\/c mice: kinetic analysis of central nervous system infection following aerosol or subcutaneous inoculation.Arch. Pathol. Lab. Med.1201996164172","journal-title":"Arch. Pathol. Lab. Med."},{"key":"e_1_3_2_42_2","first-page":"71","article-title":"Humane endpoints are an objective measure of morbidity in Venezuelan encephalomyelitis virus infection in mice","volume":"141","author":"Wright A. W.","year":"1998","unstructured":"Wright A. W. Phillpotts R. J. Humane endpoints are an objective measure of morbidity in Venezuelan encephalomyelitis virus infection in mice.Arch. Virol.14119987175","journal-title":"Arch. Virol."},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.12.2205"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.74.11.5006-5015.2000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.74.11.5006-5015.2000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T14:47:55Z","timestamp":1682261275000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.74.11.5006-5015.2000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":42,"aliases":["10.1128\/.74.11.5006-5015.2000"],"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1128\/JVI.74.11.5006-5015.2000"],"URL":"https:\/\/doi.org\/10.1128\/jvi.74.11.5006-5015.2000","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"1999-10-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-03-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}